Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS) Open new browser tab
(2022)
Start website main content
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)
(2022)